Using a legacy incumbent's multiple (PGR) is my worst-case scenario here — a mature, low-growth insurer. Even so, 19% CAGR still hugely outperforms the S&P500 average. Any re-rating above that multiple is pure upside (as the stock deserves)
To be clear — this is very basic napkin math. Dig deeper like the community has (unit economics, LTV/CAC, reserve development, loss ratios) and the disconnect between price & fundamentals looks even bigger
I might have missed this. Everyone is aware of the guidance for IFP growth from 1B-10B being 30% CAGR, but have management indicated the expected CAGR for the members growth for the same time frame?
I just recently turned 20. I have told my family the $LMND thesis and the whole family are now investors of lemonade. Has anyone else told close family/friends the endless opportunities lemonade presents?
Hey @shai_wininger & $LMND investors — Shai said the AI approved a claim in just 3.1358 seconds 🤯
Absolutely game-changing speed — but could such ultra-fast approvals pose cybersecurity or fraud risks if ever targeted by a hack? Is it not seen as a threat for $LMND software?
@shai_wininger Definitely a one-of-one community we have here. And with good reason — this company will change millions of lives for the better. We all believe in the long-term prospects of such a wonderful business and its great leadership team. 🥂🍋
Just out of curiosity.
What is everyone’s averages and total share count.
I think averages for a company like lemonade is almost irrelevant when you zoom out.
I’m at 275 shares 46$ average at 19 years old. Hopefully some more dips occur 🙏